Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several US-listed companies, including HealthEquity, HOOKIPA Pharma, SiteOne Landscape Supply, Designer Brands, Accenture, CrowdStrike, Hewlett Packard Enterprise, Keurig Dr Pepper, Relmada Therapeutics, and Entergy Corporation.
June 05, 2024 | 12:40 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Telsey Advisory Group lowered the price target for Designer Brands from $11 to $10, maintaining a Market Perform rating. Shares dipped 20.4% to close at $8.80.
The lowered price target and significant share price drop suggest strong negative sentiment, likely leading to further short-term declines.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
Goldman Sachs cut the price target for Relmada Therapeutics from $3 to $2, downgrading the stock from Neutral to Sell. Shares fell 4.2% to close at $2.95.
The reduced price target and downgrade to Sell are strong negative signals, likely leading to further short-term declines.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
Baird cut the price target for SiteOne Landscape Supply from $185 to $175, maintaining an Outperform rating. Shares dipped 10.3% to close at $136.47.
The reduced price target and significant share price drop indicate negative sentiment, likely leading to further short-term declines.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
B of A Securities cut the price target for Accenture from $419 to $365, maintaining a Buy rating. Shares gained 2.2% to close at $288.06.
Despite the reduced price target, the maintained Buy rating and share price gain indicate mixed sentiment, likely leading to neutral short-term impact.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Rosenblatt boosted the price target for CrowdStrike from $415 to $420, maintaining a Buy rating. Shares fell 1% to close at $305.58.
The increased price target and maintained Buy rating are positive, but the slight share price drop suggests mixed sentiment, likely leading to neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEUTRAL IMPACT
Wells Fargo boosted the price target for Entergy from $122 to $125, maintaining an Overweight rating. Shares fell 0.2% to close at $111.59.
The increased price target and maintained Overweight rating are positive, but the slight share price drop suggests mixed sentiment, likely leading to neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEUTRAL IMPACT
HC Wainwright & Co. boosted the price target for HOOKIPA Pharma from $5 to $6, maintaining a Buy rating. Shares fell 8.1% to close at $0.7990.
Despite the increased price target and Buy rating, the significant drop in share price suggests market skepticism or other negative factors.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEUTRAL IMPACT
B of A Securities raised the price target for Hewlett Packard Enterprise from $19 to $22, maintaining a Neutral rating. Shares fell 2% to close at $17.60.
The increased price target and maintained Neutral rating indicate mixed sentiment, likely leading to neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Keybanc raised the price target for HealthEquity from $95 to $100, maintaining an Overweight rating. Shares gained 2.7% to close at $83.40.
The increase in price target and maintained Overweight rating are positive signals, likely to boost investor confidence and share price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Wells Fargo increased the price target for Keurig Dr Pepper from $39 to $41, maintaining an Overweight rating. Shares rose 1.3% to close at $34.82.
The increased price target and maintained Overweight rating are positive signals, likely to boost investor confidence and share price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80